KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) Gross Profit (2016 - 2025)

CareDx's Gross Profit history spans 13 years, with the latest figure at $77.5 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 18.74% year-over-year to $77.5 million; the TTM value through Dec 2025 reached $277.2 million, up 10.07%, while the annual FY2025 figure was $277.2 million, 10.07% up from the prior year.
  • Gross Profit for Q4 2025 was $77.5 million at CareDx, up from $75.6 million in the prior quarter.
  • Across five years, Gross Profit topped out at $77.5 million in Q4 2025 and bottomed at -$13.8 million in Q2 2023.
  • The 5-year median for Gross Profit is $56.7 million (2022), against an average of $55.4 million.
  • The largest annual shift saw Gross Profit plummeted 125.76% in 2023 before it surged 615.34% in 2024.
  • A 5-year view of Gross Profit shows it stood at $58.4 million in 2021, then increased by 0.55% to $58.7 million in 2022, then decreased by 23.63% to $44.8 million in 2023, then soared by 45.48% to $65.2 million in 2024, then increased by 18.74% to $77.5 million in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Gross Profit are $77.5 million (Q4 2025), $75.6 million (Q3 2025), and $62.4 million (Q2 2025).